The Jackson Laboratory was founded in 1929 by Dr. Clarence Cook Little as a mammalian genetics center with a special focus on the problem of cancer, on the role of genes in both normal and abnormal development and differentiation, and on the development of the requisite genetic tools which could be put to practical use by others in examining these questions. It is the premise of The Jackson Laboratory that basic research directed towards a better understanding of the fundamental mechanisms that control normal and neoplastic growth, differentiation, and development, is essential to understand how cancers originate, develop and metastasize. The investigations pursued by members of the Scientific Staff are interdisciplinary in nature, as is illustrated by the number and diversity of internal and external collaborative projects carried out at the Laboratory. In addition to specific cancer-related research, the basic research carried out by The Jackson Laboratory investigators lays the essential ground work for a better understanding of neoplasia. Organizational capabilities and physical facilities of the Laboratory foster cohesiveness of research effort, and the deliberate avoidance of departmentalization actively promotes interdisciplinary cooperation among Scientific Staff Members. An additional factor contributing to productive research interactions is the widespread use of shared scientific resources and services, especially the genetic resources, as well as shared equipment. The Center Director is also the Director of the Laboratory and reports to the Board of Governing Trustees. The Director controls the total budget, allocates all space and makes all appointments to the Scientific Staff, subject to confirmation by the Board of Governing Trustees. The Jackson Laboratory as a whole has been designated by NCI as a Laboratory Cancer Research Center and with this application seeks continuation of it Cancer Center Support (CORE) Grant. The request is for continuing support for the current components of the grant and for additional support for two new components. CORE support is requested for only 20.6% of the total cost of the Resources and Services involved.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA034196-10
Application #
3101776
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1983-08-01
Project End
1996-07-31
Budget Start
1992-08-01
Budget End
1993-07-31
Support Year
10
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Jackson Laboratory
Department
Type
DUNS #
042140483
City
Bar Harbor
State
ME
Country
United States
Zip Code
04609
Becker, Timothy; Lee, Wan-Ping; Leone, Joseph et al. (2018) FusorSV: an algorithm for optimally combining data from multiple structural variation detection methods. Genome Biol 19:38
Wang, Qianghu; Hu, Baoli; Hu, Xin et al. (2018) Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. Cancer Cell 33:152
Richter, Wolfgang F; Christianson, Gregory J; Frances, Nicolas et al. (2018) Hematopoietic cells as site of first-pass catabolism after subcutaneous dosing and contributors to systemic clearance of a monoclonal antibody in mice. MAbs 10:803-813
Tamura, Ryo; Yoshihara, Kosuke; Saito, Tetsuya et al. (2018) Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions. Oncogenesis 7:4
Rutherford, Sarah C; Fachel, Angela A; Li, Sheng et al. (2018) Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations. Blood 132:e13-e23
Barthel, Floris P; Wesseling, Pieter; Verhaak, Roel G W (2018) Reconstructing the molecular life history of gliomas. Acta Neuropathol 135:649-670
Kim, Hyunsoo; Kumar, Pooja; Menghi, Francesca et al. (2018) High-resolution deconstruction of evolution induced by chemotherapy treatments in breast cancer xenografts. Sci Rep 8:17937
Winer, Benjamin Y; Shirvani-Dastgerdi, Elham; Bram, Yaron et al. (2018) Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection. Sci Transl Med 10:
Barthel, Floris P; Johnson, Kevin C; Wesseling, Pieter et al. (2018) Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults. Neurol Clin 36:421-437
Schechter, Lisa M; Creely, David P; Garner, Cherilyn D et al. (2018) Extensive Gene Amplification as a Mechanism for Piperacillin-Tazobactam Resistance in Escherichia coli. MBio 9:

Showing the most recent 10 out of 1156 publications